UNSPSC 51384803: Phenazopyridine

This classification denotes a nonnarcotic analgesic with the molecular formula C11H11N5, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier K2J09EMJ52, chemically known as 2,6-pyridinediamine, 3- (phenylazo)-, monohydrochloride but more generally known as phenazopyridine, which bears U.S. NIH Compound Identifier 4756. European Medicines Agency schedules Phenazopyridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09754MIG. The term PHENAZOPYRIDINE is an International Non-Proprietary Name.

World Health Organization schedules phenazopyridine in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. PHENAZOPYRIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51384803 Phenazopyridine is a Commodity code that nominally covers a specific urinary analgesic pharmaceutical, but recent state and local procurement activity tagged under this code does not align with the code's stated scope. Seminole County, Florida posted an IFB in June 2026 seeking Naloxone and Safe Drug Deactivation Systems — opioid-reversal medication and harm-reduction equipment — which fall outside the phenazopyridine category entirely. The mismatch suggests either a coding error in the county's e-Procurement Portal or a broader tagging practice that conflates pharmaceutical procurement codes. State and local buyers using this code appear to include county health departments and community health agencies pursuing emergency medical supplies and addiction-response resources through competitive bid processes.

The single recent opportunity of record is Seminole County, Florida (IFB 60459723LAS, response due July 26, 2023) for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract includes a two-year initial term with one-year renewal option, fixed-fee pricing, and standard compliance requirements including drug-free workplace certification, E-Verify, and commercial insurance. The procurement may be funded through FEMA, introducing federal regulatory overlay. Beyond this single posting, the code shows no additional recent state and local activity, indicating minimal or scattered use under the phenazopyridine category heading in state and local procurement.